Discover 10 dividend growth powerhouses that could turbocharge your portfolio's long-term performance.
Amgen is expected to release its fiscal second-quarter earnings next month, and analysts project a single-digit profit dip.
Amgen offers a packed pipeline and healthy dividend distributions.
Revenue is climbing at these two drug companies -- and the trend should continue.
What's better than a dividend? A dividend that's growing.
This pharma company is posting double-digit revenue growth.
Eli Lilly is a good stock to buy, but these should be even better.
This company's payouts look safe.
Amgen's market-beating ways are unlikely to evaporate any time soon.
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:KYMR),(NASDAQ:GILD),(OTCQX:RHHBY),(NASDAQ:AMGN) EQNX::TICKER_END